Influencing and shaping our sector | BIA update January - April 2019
24 April 2019
Influencing and shaping our sector | BIA update January - April 2019
The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2019.
Claire Smith, who sits on BIA’s Intellectual Property Advisory Committee (IPAC) committee, and James Johnston explain what the US BIOSECURE Act means for UK biotech companies
Opening for participation on September 2nd 2026, PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study will provide a comprehensive, data-driven view of board remuneration, composition and diversity across the European and UK life sciences sector.
Chris Molloy on Mike Hoare, the RedX-Skye deal, Stablepharma’s fridge-free vaccine, MHRA quarterly numbers, ministerial responsibilities for UK life sciences and human biology-based models
